Idelalisib Recruiting Phase 1 Trials for Peripheral T-Cell Lymphoma (PTCL) / Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs